PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.\', \'Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Stemirna Therapeutics Inc., Shanghai, China.\', \'Stanford University Medical Center, Stanford, California, USA.\', \'Health Care Services Stockholm County (SLSO), Stockholm, Sweden.\', \'Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Clinical Microbiology and.\', \'Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1172/JCI144734144734
?:doi
?:hasPublicationType
?:journal
  • The Journal of clinical investigation
is ?:pmid of
?:pmid
?:pmid
  • 33492309
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all